Atlas Trials

Prediction of Bleeding Risk After Anticoagulant Therapy for Atrial Fibrillation Based on Proteomics and Metabolomics

Clinical trial NCT05181774 · UNKNOWN

Trial details

NCT number
NCT05181774
Sponsor
Yue LI
Status
UNKNOWN
Study type
OBSERVATIONAL
Atrial FibrillationBleedingAnticoagulant Therapy
Start date
2021-12-20
Primary completion
2023-12-31
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.